Unlock instant, AI-driven research and patent intelligence for your innovation.

A composition for synchronously adjusting glucose and lipid metabolism to treat type 2 diabetes

A technology for diabetes and lipid metabolism disorders, applied in the direction of metabolic diseases, drug combinations, active ingredients of hydroxyl compounds, etc., can solve problems such as lowering blood sugar, side effects, and inability to simultaneously reduce obesity

Active Publication Date: 2019-01-25
XIYUAN HOSPITAL OF CHINA ACAD OF CHINESE MEDICAL SCI
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The present invention aims to provide the application of a composition of coix soluble cellulose and honokiol in pharmaceuticals. By using the combination of coix soluble cellulose and honokiol according to a specific example, the coix soluble cellulose can significantly improve the The bioavailability of honokiol, the two have a significant synergistic effect, solving the technical problems of serious side effects and other adverse reactions of drugs for treating diabetes in the prior art, and the inability to simultaneously reduce obesity while lowering blood sugar

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A composition for synchronously adjusting glucose and lipid metabolism to treat type 2 diabetes
  • A composition for synchronously adjusting glucose and lipid metabolism to treat type 2 diabetes
  • A composition for synchronously adjusting glucose and lipid metabolism to treat type 2 diabetes

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] 1.1 Purpose of the experiment

[0029] KK / Upj-Ay mice were given high-fat diet to create a type II diabetes model, and KK / Upj-Ay mice that had been successfully induced into the model were given honokiol by intragastric administration, and the effect of honokiol on type II diabetic mice was investigated. Hypoglycemic effect of the model.

[0030] 1.2 Test samples

[0031] Honokiol was prepared by Xiyuan Hospital, China Academy of Chinese Medical Sciences. Set up three dosage groups of low, middle and high, and the dosages are 25mg / kg / d, 50mg / kg / d and 100mg / kg / d respectively. Prepare suspensions with concentrations of 2.5mg / ml, 5mg / ml and 10mg / ml with sterile water.

[0032] 1.3 Positive control drugs

[0033] Get pioglitazone hydrochloride tablet (15mg * 7 pieces, batch number is 120202, production date is January 31, 2012, valid until December, 2014, produced by Beijing Sun Pharmaceutical Co., Ltd.), ground into fine powder, weighed 40 mg, plus 20 mL of distilled ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a composition for synchronous adjustment of glucolipid metabolism and treatment of type II diabetes. A composition of Coix lacryma-jobi water-soluble cellulose and honokiol has the efficacy of improving insulin resistance, also can improve lipid metabolism disorder while lowering blood glucose and reduce weight. Single oral administration application of Coix lacryma-jobi water-soluble cellulose cannot reach the efficacy of lowering blood sugar and improving blood lipid, honokiol has efficacy of synchronous adjustment of blood glucose and blood lipid, but has large dosage. Through proper compatibility of Coix lacryma-jobi water-soluble cellulose and honokiol, Coix lacryma-jobi water-soluble cellulose and honokiol are applied in a composition form, thus reducing the dosage of honokiol to one fifth that of its single use, and the blood glucose lowering efficacy is significantly superior to its separate use. Coix lacryma-jobi water-soluble cellulose and honokiol have obvious synergistic effect, and application of the two as a composition can achieve obvious advantages.

Description

technical field [0001] The invention relates to the application of the composition of coix soluble cellulose and honokiol, in particular to the application of the composition of coix soluble cellulose and honokiol in pharmacy. Background technique [0002] Diabetes mellitus is a chronic endocrine and metabolic disease characterized by hyperglycemia. Its pathological basis is absolute and / or relative lack of insulin, which in turn causes a series of metabolic disorders of sugar, fat, protein, water and electrolytes. The vast majority of diabetes is type II, accounting for 90%-95% of the total number of diabetic patients. According to the epidemic trend forecast, by 2030, the global adults aged 20-79 suffering from diabetes will reach a staggering number of 439 million. Diabetes has become a major disease that seriously endangers human health, and research on its prevention and control has attracted great attention from all over the world. [0003] The key to the treatment o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/717A61P3/10A61P3/04A61P5/50A61K31/05
Inventor 王建农
Owner XIYUAN HOSPITAL OF CHINA ACAD OF CHINESE MEDICAL SCI